EW
Price
$92.01
Change
-$2.43 (-2.57%)
Updated
Oct 30 closing price
Capitalization
53.03B
4 days until earnings call
Intraday BUY SELL Signals
SIBN
Price
$21.23
Change
-$1.18 (-5.27%)
Updated
Oct 30 closing price
Capitalization
951.5M
2 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EW vs SIBN

EW vs SIBN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
EW vs. SIBN commentary
Nov 01, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EW is a Buy and SIBN is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for EW with price predictions
Oct 30, 2026

EW in upward trend: price rose above 50-day moving average on October 21, 2026

EW moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend. In 36 of 46 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on EW as a result. In 55 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.

The Moving Average Convergence Divergence (MACD) for EW just turned positive on October 14, 2026. Looking at past instances where EW's MACD turned positive, the stock continued to rise in 27 of 43 cases over the following month. The odds of a continued upward trend are 63%.

The 10-day moving average for EW crossed bullishly above the 50-day moving average on October 27, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 76%.

Following a +3.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where EW advanced for three days, in 172 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.

Bearish Trend Analysis

The 10-day RSI Indicator for EW moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 16 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 57%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

EW broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for EW entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 28 (best 1 - 100 worst), indicating outstanding price growth. EW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 72 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.995) is normal, around the industry mean (4.201). P/E Ratio (52.879) is within average values for comparable stocks, (1.335). Projected Growth (PEG Ratio) (1.852) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (7.974) is also within normal values, averaging (40.124).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for SIBN with price predictions
Oct 30, 2026

SIBN in upward trend: price rose above 50-day moving average on October 05, 2026

SIBN moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend. In 27 of 34 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on SIBN as a result. In 62 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.

The Moving Average Convergence Divergence (MACD) for SIBN just turned positive on October 05, 2026. Looking at past instances where SIBN's MACD turned positive, the stock continued to rise in 37 of 48 cases over the following month. The odds of a continued upward trend are 77%.

The 10-day moving average for SIBN crossed bullishly above the 50-day moving average on October 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.

Following a +4.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where SIBN advanced for three days, in 211 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

The Aroon Indicator entered an Uptrend today. In 138 of 194 cases where SIBN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.

Bearish Trend Analysis

The 10-day RSI Indicator for SIBN moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 20 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 74%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SIBN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

SIBN broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 10 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.218) is normal, around the industry mean (4.201). P/E Ratio (-64.333) is within average values for comparable stocks, (1.335). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (3.801) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. SIBN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 74 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 96 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SIBN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
EW vs SIBN: Fundamental Ratings
EW
SIBN
OUTLOOK RATING
1..100
2416
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
10
Undervalued
PROFIT vs RISK RATING
1..100
10096
SMR RATING
1..100
7293
PRICE GROWTH RATING
1..100
2836
P/E GROWTH RATING
1..100
874
SEASONALITY SCORE
1..100
5012

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIBN's Valuation (10) in the Medical Specialties industry is significantly better than the same rating for EW (91). This means that SIBN’s stock grew significantly faster than EW’s over the last 12 months.

SIBN's Profit vs Risk Rating (96) in the Medical Specialties industry is in the same range as EW (100). This means that SIBN’s stock grew similarly to EW’s over the last 12 months.

EW's SMR Rating (72) in the Medical Specialties industry is in the same range as SIBN (93). This means that EW’s stock grew similarly to SIBN’s over the last 12 months.

EW's Price Growth Rating (28) in the Medical Specialties industry is in the same range as SIBN (36). This means that EW’s stock grew similarly to SIBN’s over the last 12 months.

EW's P/E Growth Rating (8) in the Medical Specialties industry is significantly better than the same rating for SIBN (74). This means that EW’s stock grew significantly faster than SIBN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EWSIBN
RSI
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 24 days ago
60%
Bearish Trend 6 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
71%
COMPARISON
Comparison
Nov 01, 2026
Stock price -- (EW: $92.01 vs. SIBN: $21.23)
Brand notoriety: EW: Notable vs. SIBN: Not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: EW: 167% vs. SIBN: 165%
Market capitalization -- EW: $53.03B vs. SIBN: $951.5M
EW [@Medical/Nursing Services] is valued at $53.03B. SIBN’s [@Medical/Nursing Services] market capitalization is $951.5M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $183.77B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EW’s FA Score shows that 2 FA rating(s) are green while SIBN’s FA Score has 1 green FA rating(s).

  • EW’s FA Score: 2 green, 3 red.
  • SIBN’s FA Score: 1 green, 4 red.
According to our system of comparison, both EW and SIBN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EW’s TA Score shows that 5 TA indicator(s) are bullish while SIBN’s TA Score has 6 bullish TA indicator(s).

  • EW’s TA Score: 5 bullish, 5 bearish.
  • SIBN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SIBN is a better buy in the short-term than EW.

Price Growth

EW (@Medical/Nursing Services) experienced а +3.30% price change this week, while SIBN (@Medical/Nursing Services) price change was -1.16% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.04%. For the same industry, the average monthly price growth was -8.74%, and the average quarterly price growth was -9.59%.

Reported Earning Dates

EW is expected to report earnings on Nov 04, 2026.

SIBN is expected to report earnings on Nov 02, 2026.

Industries' Descriptions

@Medical/Nursing Services (+0.04% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
EW
Daily Signal:
Gain/Loss:
SIBN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

SIBN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SIBN has been loosely correlated with ATEC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SIBN jumps, then ATEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIBN
1D Price
Change %
SIBN100%
-5.27%
ATEC - SIBN
52%
Loosely correlated
-38.08%
OFIX - SIBN
48%
Loosely correlated
-11.43%
MDT - SIBN
45%
Loosely correlated
-0.59%
STE - SIBN
42%
Loosely correlated
-2.16%
PODD - SIBN
41%
Loosely correlated
-1.85%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RMIX10.510.14
+1.30%
Suncrete Inc.
BANF110.31-1.13
-1.01%
BancFirst Corp
CPNG14.37-0.20
-1.37%
Coupang
SJT3.29-0.11
-3.24%
San Juan Basin Royalty Trust UBI
GTBP5.32-0.28
-5.00%
GT Biopharma Inc